ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

Other Contract Concepts Approved By DCE Board

March 10, 1989

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013